FDA · Drug recall
Venlafaxine Tablets…
- Date
- Aug. 18, 2021
- Risk class
- Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)
- Status
- Terminated
- Filed by
- Sun Pharmaceutical Industries Inc
- Product
- Venlafaxine Tablets, USP 50 mg*, 100 Tablets Manufactured for Northstar Rx LLC Memphis, TN 38141 Manufactured by: ALKALOIDA Chemical Company Zrt. 4440 Tiszavasvari, Kabay Janos u.29.Hungary. Product of India NDC 16714-657-01
- Reason
- Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg
- Distribution pattern
- Northstar Distribution Center 4853 Crumpler Rd. Memphis, TN 38141
- Quantity
- 2856 bottles
- Codes and lots
- AVK1175A, exp 9/2023
- Recall started
- July 29, 2021
- Recall number
- D-0703-2021
What should I do? Medicine recall: what to do
Source: FDA · Drug enforcement report, recall number D-0703-2021. The agency record governs; check it and the company before acting.